Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 1
2020 3
2021 4
2022 6
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Nuxcell Neo® improves vaccine efficacy in antibody response.
Jesus GFA, Galvani NC, Abel JDS, Scussel R, Fagundes MĹ, Córneo EDS, Rossetto M, Sargiani D, de Ávila RAM, Michels M. Jesus GFA, et al. Front Vet Sci. 2024 Feb 13;11:1248811. doi: 10.3389/fvets.2024.1248811. eCollection 2024. Front Vet Sci. 2024. PMID: 38414656 Free PMC article.
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasis.
Vale DL, Machado AS, Ramos FF, Lage DP, Freitas CS, de Oliveira D, Galvani NC, Luiz GP, Fagundes MI, Fernandes BB, Oliveira-da-Silva JA, Ludolf F, Tavares GSV, Guimarães NS, Chaves AT, Chávez-Fumagalli MA, Tupinambás U, Rocha MOC, Gonçalves DU, Martins VT, Machado-de-Ávila RA, Coelho EAF. Vale DL, et al. Among authors: galvani nc. Microb Pathog. 2022 Jun;167:105562. doi: 10.1016/j.micpath.2022.105562. Epub 2022 May 2. Microb Pathog. 2022. PMID: 35513293
Immunoproteomics approach for the discovery of antigens applied to the diagnosis of canine visceral leishmaniasis.
Costa SS, Santos LMO, Freire LC, Tedeschi ALF, Ribeiro NR, Queiroz MHR, Neto EB, Pimenta DC, Galvani NC, Luiz GP, de Oliveira ME, de Ávila RAM, Carvalho AMRS, Brigido BVS, Reis AB, Fernandes APSM, Coelho EAF, Roatt BM, Menezes-Souza D, Duarte MC. Costa SS, et al. Acta Trop. 2023 May;241:106865. doi: 10.1016/j.actatropica.2023.106865. Epub 2023 Feb 12. Acta Trop. 2023. PMID: 36787861
Evaluation of the in vivo acute toxicity of poly(thioether-ester) and superparamagnetic poly(thioether-ester) nanoparticles obtained by thiol-ene miniemulsion polymerization.
Feuser PE, Cardoso MM, Galvani NC, Zaccaron RP, Venturini LM, Rigo FK, Machado-de-Ávila RA, Silveira PCL, Sayer C, Hermes de Araújo PH. Feuser PE, et al. J Biomed Mater Res B Appl Biomater. 2022 Mar;110(3):702-711. doi: 10.1002/jbm.b.34949. Epub 2021 Oct 7. J Biomed Mater Res B Appl Biomater. 2022. PMID: 34619018
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
Ribeiro PAF, Vale DL, Dias DS, Lage DP, Mendonça DVC, Ramos FF, Carvalho LM, Carvalho AMRS, Steiner BT, Roque MC, Oliveira-da-Silva JA, Oliveira JS, Tavares GSV, Galvani NC, Martins VT, Chávez-Fumagalli MA, Roatt BM, Moreira RLF, Menezes-Souza D, Oliveira MC, Machado-de-Ávila RA, Teixeira AL, Coelho EAF. Ribeiro PAF, et al. Among authors: galvani nc. Cytokine. 2020 May;129:155031. doi: 10.1016/j.cyto.2020.155031. Epub 2020 Feb 12. Cytokine. 2020. PMID: 32062145
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection.
Lage DP, Vale DL, Linhares FP, Freitas CS, Machado AS, Cardoso JMO, de Oliveira D, Galvani NC, de Oliveira MP, Oliveira-da-Silva JA, Ramos FF, Tavares GSV, Ludolf F, Bandeira RS, Pereira IAG, Chávez-Fumagalli MA, Roatt BM, Machado-de-Ávila RA, Christodoulides M, Coelho EAF, Martins VT. Lage DP, et al. Among authors: galvani nc. Vaccines (Basel). 2022 Jul 19;10(7):1146. doi: 10.3390/vaccines10071146. Vaccines (Basel). 2022. PMID: 35891310 Free PMC article.
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins.
Galvani NC, Machado AS, Lage DP, Martins VT, de Oliveira D, Freitas CS, Vale DL, Fernandes BB, Oliveira-da-Silva JA, Reis TAR, Santos TTO, Ramos FF, Bandeira RS, Ludolf F, Tavares GSV, Guimarães NS, Tupinambás U, Chávez-Fumagalli MA, Humbert MV, Gonçalves DU, Christodoulides M, Machado-de-Ávila RA, Coelho EAF. Galvani NC, et al. Microb Pathog. 2022 Jan;162:105341. doi: 10.1016/j.micpath.2021.105341. Epub 2021 Dec 6. Microb Pathog. 2022. PMID: 34883228
16 results